Cargando…

Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways

Glioblastoma (GBM) is the most commonly diagnosed brain tumor that exhibit high mortality rate and chemotherapy resistance is a major clinical problem. Recent studies suggest that estrogen receptor beta (ERβ), may function as a tumor suppressor in GBM. However, the mechanism(s) by which ERβ contribu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Mei, Sareddy, Gangadhara R., Li, Mengxing, Liu, Jinyou, Luo, Yiliao, Venkata, Prabhakar Pitta, Viswanadhapalli, Suryavathi, Tekmal, Rajeshwar R., Brenner, Andrew, Vadlamudi, Ratna K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467924/ https://www.ncbi.nlm.nih.gov/pubmed/30992459 http://dx.doi.org/10.1038/s41598-019-42313-8

Ejemplares similares

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
por: Liu, Jinyou, et al.
Publicado: (2017)

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma
por: Pratap, Uday P, et al.
Publicado: (2021)

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
por: Sareddy, Gangadhara R., et al.
Publicado: (2016)

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2019)

Brain-Derived Estrogen and Neurological Disorders
por: Brann, Darrell W., et al.
Publicado: (2022)

Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling
por: Liu, Junhao, et al.
Publicado: (2021)

PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
por: Sareddy, Gangadhara R, et al.
Publicado: (2019)

Neuron-Derived Estrogen—A Key Neuromodulator in Synaptic Function and Memory
por: Brann, Darrell W., et al.
Publicado: (2021)

Brain-derived estrogen and neural function
por: Brann, Darrell W., et al.
Publicado: (2022)

Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist
por: He, Yi, et al.
Publicado: (2022)

Neuron-Derived Estrogen Is Critical for Astrocyte Activation and Neuroprotection of the Ischemic Brain
por: Lu, Yujiao, et al.
Publicado: (2020)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
por: Tang, Weiwei, et al.
Publicado: (2021)

Global Genomic and Proteomic Analysis Identified Critical Pathways Modulated by Proto-Oncogene PELP1 in TNBC
por: Liu, Zexuan, et al.
Publicado: (2022)

Development and Characterization of Inducible Astrocyte-Specific Aromatase Knockout Mice
por: Wang, Jing, et al.
Publicado: (2023)

SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
por: Liu, Zexuan, et al.
Publicado: (2022)

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
por: Li, Mengxing, et al.
Publicado: (2021)

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth
por: Blankenship, Logan, et al.
Publicado: (2022)

301 Inhibition of lysine-specific histone demethylase 1A (KDM1A/LSD1) attenuates DNA double strand break repair and enhances efficacy of temozolomide in glioblastoma
por: Alejo, Salvador, et al.
Publicado: (2023)

2114: The role of estrogen receptor-β in the development of the early endometriotic lesion
por: Knudtson, Jennifer, et al.
Publicado: (2018)

Neuron-Derived Estrogen Regulates Synaptic Plasticity and Memory
por: Lu, Yujiao, et al.
Publicado: (2019)

Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
por: Altwegg, Kristin A., et al.
Publicado: (2023)

The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events
por: Timilsina, Santosh, et al.
Publicado: (2022)

Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
por: Nair, Binoj C, et al.
Publicado: (2011)

Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress
por: Liu, Xihui, et al.
Publicado: (2022)

Targeting LIF/LIFR signaling in cancer
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2021)

Regulation of rDNA Transcription by Proto-Oncogene PELP1
por: Gonugunta, Vijay K., et al.
Publicado: (2011)

NLRP3 Inflammasome Activation in the Brain after Global Cerebral Ischemia and Regulation by 17β-Estradiol
por: Thakkar, Roshni, et al.
Publicado: (2016)

Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway
por: Bowers, Laura W., et al.
Publicado: (2015)

KDM1 is a novel therapeutic target for the treatment of gliomas
por: Sareddy, Gangadhara R., et al.
Publicado: (2012)

Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
por: Roy, Sudipa Saha, et al.
Publicado: (2013)

Regulation and Role of Neuron-Derived Hemoglobin in the Mouse Hippocampus
por: Lu, Yujiao, et al.
Publicado: (2022)

Role of Estrogen Receptor Signaling in Breast Cancer Metastasis
por: Saha Roy, Sudipa, et al.
Publicado: (2012)

Aromatase Expression Increases the Survival and Malignancy of Estrogen Receptor Positive Breast Cancer Cells
por: Mukhopadhyay, Keya De, et al.
Publicado: (2015)

Role of estrogen receptor coregulators in endocrine resistant breast cancer
por: Altwegg, Kristin A., et al.
Publicado: (2021)

EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling
por: Yue, Xuetian, et al.
Publicado: (2020)

Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy
por: Mann, Monica, et al.
Publicado: (2011)

Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer
por: Gupta, Harshita B, et al.
Publicado: (2016)

Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
por: Mączyńska, Justyna, et al.
Publicado: (2022)

Differences in creep response of GBM cells migrating in confinement
por: Khan, Ishan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e2dqhtbppg4kj69klna2fif7fj